Erratum: Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.